Kenya National Cancer Control Programme (NCCP) Implementation Guide - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Active as of 2026-08-18 |
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
<http://hl7.org/fhir/CodeSystem/ocm-protocol-markers-cs> a fhir:CodeSystem ;
fhir:nodeRole fhir:treeRoot ;
fhir:Resource.id [ fhir:value "ocm-protocol-markers-cs"] ;
fhir:Resource.language [ fhir:value "en"] ;
fhir:DomainResource.text [
fhir:Narrative.status [ fhir:value "generated" ] ;
fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem ocm-protocol-markers-cs</b></p><a name=\"ocm-protocol-markers-cs\"> </a><a name=\"hcocm-protocol-markers-cs\"> </a><p>This case-sensitive code system <code>https://fhir.dha.go.ke/terminology/CodeSystem/ocm-protocol-markers-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">HER2-POSITIVE<a name=\"ocm-protocol-markers-cs-HER2-POSITIVE\"> </a></td><td>HER2 Positive</td><td>HER2/neu overexpression or amplification detected.</td></tr><tr><td style=\"white-space:nowrap\">HER2-NEGATIVE<a name=\"ocm-protocol-markers-cs-HER2-NEGATIVE\"> </a></td><td>HER2 Negative</td><td>No HER2/neu overexpression or amplification.</td></tr><tr><td style=\"white-space:nowrap\">ER-POSITIVE<a name=\"ocm-protocol-markers-cs-ER-POSITIVE\"> </a></td><td>ER Positive</td><td>Oestrogen receptor positive.</td></tr><tr><td style=\"white-space:nowrap\">ER-NEGATIVE<a name=\"ocm-protocol-markers-cs-ER-NEGATIVE\"> </a></td><td>ER Negative</td><td>Oestrogen receptor negative.</td></tr><tr><td style=\"white-space:nowrap\">PR-POSITIVE<a name=\"ocm-protocol-markers-cs-PR-POSITIVE\"> </a></td><td>PR Positive</td><td>Progesterone receptor positive.</td></tr><tr><td style=\"white-space:nowrap\">PR-NEGATIVE<a name=\"ocm-protocol-markers-cs-PR-NEGATIVE\"> </a></td><td>PR Negative</td><td>Progesterone receptor negative.</td></tr><tr><td style=\"white-space:nowrap\">TRIPLE-NEGATIVE<a name=\"ocm-protocol-markers-cs-TRIPLE-NEGATIVE\"> </a></td><td>Triple Negative</td><td>ER-, PR-, HER2- breast cancer.</td></tr><tr><td style=\"white-space:nowrap\">KRAS-MUTANT<a name=\"ocm-protocol-markers-cs-KRAS-MUTANT\"> </a></td><td>KRAS Mutant</td><td>KRAS mutation detected.</td></tr><tr><td style=\"white-space:nowrap\">KRAS-WILD-TYPE<a name=\"ocm-protocol-markers-cs-KRAS-WILD-TYPE\"> </a></td><td>KRAS Wild-type</td><td>No KRAS mutation.</td></tr><tr><td style=\"white-space:nowrap\">BRAF-V600E<a name=\"ocm-protocol-markers-cs-BRAF-V600E\"> </a></td><td>BRAF V600E Mutant</td><td>BRAF V600E mutation detected.</td></tr><tr><td style=\"white-space:nowrap\">PD-L1-POSITIVE<a name=\"ocm-protocol-markers-cs-PD-L1-POSITIVE\"> </a></td><td>PD-L1 Positive</td><td>PD-L1 expression ≥1%.</td></tr><tr><td style=\"white-space:nowrap\">PD-L1-NEGATIVE<a name=\"ocm-protocol-markers-cs-PD-L1-NEGATIVE\"> </a></td><td>PD-L1 Negative</td><td>PD-L1 expression <1%.</td></tr><tr><td style=\"white-space:nowrap\">MSI-HIGH<a name=\"ocm-protocol-markers-cs-MSI-HIGH\"> </a></td><td>MSI-High</td><td>Microsatellite instability high.</td></tr><tr><td style=\"white-space:nowrap\">MSI-LOW<a name=\"ocm-protocol-markers-cs-MSI-LOW\"> </a></td><td>MSI-Low / MSS</td><td>Microsatellite instability low or stable.</td></tr><tr><td style=\"white-space:nowrap\">EGFR-MUTANT<a name=\"ocm-protocol-markers-cs-EGFR-MUTANT\"> </a></td><td>EGFR Mutant</td><td>EGFR mutation detected.</td></tr><tr><td style=\"white-space:nowrap\">ALK-POSITIVE<a name=\"ocm-protocol-markers-cs-ALK-POSITIVE\"> </a></td><td>ALK Positive</td><td>ALK rearrangement detected.</td></tr><tr><td style=\"white-space:nowrap\">NOT-TESTED<a name=\"ocm-protocol-markers-cs-NOT-TESTED\"> </a></td><td>Not Tested</td><td>Biomarker testing not performed.</td></tr></table></div>"
] ;
fhir:CodeSystem.url [ fhir:value "https://fhir.dha.go.ke/terminology/CodeSystem/ocm-protocol-markers-cs"] ;
fhir:CodeSystem.version [ fhir:value "1.0.0"] ;
fhir:CodeSystem.name [ fhir:value "OCMProtocolMarkersCS"] ;
fhir:CodeSystem.title [ fhir:value "Kenya OCM Protocol Markers Code System"] ;
fhir:CodeSystem.status [ fhir:value "active"] ;
fhir:CodeSystem.experimental [ fhir:value "false"^^xsd:boolean] ;
fhir:CodeSystem.date [ fhir:value "2026-08-18T08:00:19+00:00"^^xsd:dateTime] ;
fhir:CodeSystem.publisher [ fhir:value "Digital Health Agency (DHA), Kenya"] ;
fhir:CodeSystem.contact [
fhir:index -1 ;
fhir:ContactDetail.name [ fhir:value "Digital Health Agency (DHA), Kenya" ] ;
fhir:ContactDetail.telecom [
fhir:index -1 ;
fhir:ContactPoint.system [ fhir:value "url" ] ;
fhir:ContactPoint.value [ fhir:value "https://dha.go.ke" ]
], [
fhir:index -1 ;
fhir:ContactPoint.system [ fhir:value "email" ] ;
fhir:ContactPoint.value [ fhir:value "info@dha.go.ke" ]
]
], [
fhir:index -1 ;
fhir:ContactDetail.name [ fhir:value "Digital Health Agency Kenya – FHIR Team" ] ;
fhir:ContactDetail.telecom [
fhir:index -1 ;
fhir:ContactPoint.system [ fhir:value "email" ] ;
fhir:ContactPoint.value [ fhir:value "info@dha.go.ke" ] ;
fhir:ContactPoint.use [ fhir:value "work" ]
], [
fhir:index -1 ;
fhir:ContactPoint.system [ fhir:value "url" ] ;
fhir:ContactPoint.value [ fhir:value "https://dha.go.ke" ] ;
fhir:ContactPoint.use [ fhir:value "work" ]
]
] ;
fhir:CodeSystem.description [ fhir:value "Biomarker and molecular marker codes used for treatment protocol selection."] ;
fhir:CodeSystem.jurisdiction [
fhir:index -1 ;
fhir:CodeableConcept.coding [
fhir:index -1 ;
fhir:Coding.system [ fhir:value "urn:iso:std:iso:3166" ] ;
fhir:Coding.code [ fhir:value "KE" ] ;
fhir:Coding.display [ fhir:value "Kenya" ]
]
] ;
fhir:CodeSystem.caseSensitive [ fhir:value "true"^^xsd:boolean] ;
fhir:CodeSystem.content [ fhir:value "complete"] ;
fhir:CodeSystem.count [ fhir:value "17"^^xsd:nonNegativeInteger] ;
fhir:CodeSystem.concept [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "HER2-POSITIVE" ] ;
fhir:CodeSystem.concept.display [ fhir:value "HER2 Positive" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "HER2/neu overexpression or amplification detected." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "HER2-NEGATIVE" ] ;
fhir:CodeSystem.concept.display [ fhir:value "HER2 Negative" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "No HER2/neu overexpression or amplification." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "ER-POSITIVE" ] ;
fhir:CodeSystem.concept.display [ fhir:value "ER Positive" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "Oestrogen receptor positive." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "ER-NEGATIVE" ] ;
fhir:CodeSystem.concept.display [ fhir:value "ER Negative" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "Oestrogen receptor negative." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "PR-POSITIVE" ] ;
fhir:CodeSystem.concept.display [ fhir:value "PR Positive" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "Progesterone receptor positive." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "PR-NEGATIVE" ] ;
fhir:CodeSystem.concept.display [ fhir:value "PR Negative" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "Progesterone receptor negative." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "TRIPLE-NEGATIVE" ] ;
fhir:CodeSystem.concept.display [ fhir:value "Triple Negative" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "ER-, PR-, HER2- breast cancer." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "KRAS-MUTANT" ] ;
fhir:CodeSystem.concept.display [ fhir:value "KRAS Mutant" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "KRAS mutation detected." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "KRAS-WILD-TYPE" ] ;
fhir:CodeSystem.concept.display [ fhir:value "KRAS Wild-type" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "No KRAS mutation." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "BRAF-V600E" ] ;
fhir:CodeSystem.concept.display [ fhir:value "BRAF V600E Mutant" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "BRAF V600E mutation detected." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "PD-L1-POSITIVE" ] ;
fhir:CodeSystem.concept.display [ fhir:value "PD-L1 Positive" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "PD-L1 expression ≥1%." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "PD-L1-NEGATIVE" ] ;
fhir:CodeSystem.concept.display [ fhir:value "PD-L1 Negative" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "PD-L1 expression <1%." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "MSI-HIGH" ] ;
fhir:CodeSystem.concept.display [ fhir:value "MSI-High" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "Microsatellite instability high." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "MSI-LOW" ] ;
fhir:CodeSystem.concept.display [ fhir:value "MSI-Low / MSS" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "Microsatellite instability low or stable." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "EGFR-MUTANT" ] ;
fhir:CodeSystem.concept.display [ fhir:value "EGFR Mutant" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "EGFR mutation detected." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "ALK-POSITIVE" ] ;
fhir:CodeSystem.concept.display [ fhir:value "ALK Positive" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "ALK rearrangement detected." ]
], [
fhir:index -1 ;
fhir:CodeSystem.concept.code [ fhir:value "NOT-TESTED" ] ;
fhir:CodeSystem.concept.display [ fhir:value "Not Tested" ] ;
fhir:CodeSystem.concept.definition [ fhir:value "Biomarker testing not performed." ]
] .
# - ontology header ------------------------------------------------------------
<http://hl7.org/fhir/CodeSystem/ocm-protocol-markers-cs.ttl> a owl:Ontology ;
owl:imports fhir:fhir.ttl ;
owl:versionIRI <http://build.fhir.org/CodeSystem/ocm-protocol-markers-cs.ttl> .
IG © 2026+ Digital Health Agency (DHA), Kenya.
Package ke.fhir.nccp#1.0.0 based on FHIR 4.0.1.
Generated
2026-08-18
Links: Table of Contents |
QA Report